MTNB vs VTRS · $5.6M cap vs rev $7.27B
Matinas BioPharma Holdings Inc (MTNB) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
MTNB does not have a complete income-statement cache yet.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
MTNB currently screens at market cap $5.6M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the MTNB and VTRS stock pages for the full models.
Not investment advice.